Every deal we've covered

Command Medical Products, an Argosy Healthcare Partners portfolio company, acquired Injection Moulding & Tooling Services S.A., a Costa Rica-based injection molding and tooling provider.

Grünenthal agreed to acquire the oral cancer treatment Stivarga (regorafenib) from Bayer AG for up to €375 million, with closing expected by end of 2026 or early 2027.

PTC Therapeutics completed its acquisition of ST-920, a BLA-stage AAV gene therapy for Fabry disease, from Sangamo Therapeutics.

Telix Pharmaceuticals signed a strategic agreement to lead a merger with ITM Isotope Technologies Munich, a private radioisotope producer that reported US$273 million of 2025 revenue.

Veridian Healthcare, backed by HealthEdge Investment Partners and United Western Group, completed the acquisition of the ScarScience brand and related assets from Mitchell-Vance Laboratories.

111 Inc.'s board received an unsolicited non-binding proposal from its co-founders and Huadeng Tech BioArray Ventures to take the Chinese healthcare platform private at $4.52 per ADS in cash.

Aethlon Medical entered a definitive all-stock merger agreement with North Immunology, alongside an oversubscribed $180 million private placement funding operations into 2028.

Switzerland's Medartis Group acquired the M.A.R.C. Institute in Doral, Florida, a surgical training and bioskills research facility with 36 surgical stations.

NMS Capital recapitalized Endoscopy Corporation of America and acquired Medical Optics from Probo Medical, combining them into new surgical MRO platform Asurgence Medical.

MD Esthetics, a New Harbor Capital portfolio company, completed four medical aesthetics add-on acquisitions in H1 2026, growing from 12 to 35 locations and entering Pennsylvania and Vermont.

MRO acquired Vyne Medical, a data intake and intelligent document processing provider serving over 800 hospitals, expanding its enterprise clinical data management platform.

CGF Holdings announced a strategic investment in MediPro Direct, a nationwide mobile diagnostics services provider, marking the Grant family's return to diagnostics.

Medallion acquired Andros, an NCQA-certified credentials verification organization, adding over a million providers across nearly 400 healthcare organizations.

Jazz Pharmaceuticals closed its acquisition of privately held Actio Biosciences for $820 million upfront, adding KCNT1-related epilepsy candidate ABS-1230.

Arsenal Capital-backed Endpoint Clinical acquired Boston-based Bluefin, a clinical supply forecasting and planning technology provider, which will operate independently.

Spa Medicca announced a partnership bringing women's health practice Dr. Nicholas E. Sherock LLC & Associates into its Ohio platform.

Medtronic commenced an exchange offer to split off at least 80.1% of MiniMed Group shares, letting Medtronic shareholders swap ordinary shares for MiniMed stock in a generally tax-free transaction.

Michigan-based Daia Orthodontics & TMJ Orthopedics expanded into Canada by acquiring four former docbraces clinics in New Brunswick and Prince Edward Island.

Newly formed medical device company Jaguar LAA acquired assets of the Laminar left atrial appendage closure program from Johnson & Johnson; terms undisclosed.

LUX Infusion acquired South Jersey Pediatric and Adult Infusion Center and Northeast Infusion Therapy, expanding its clinician-led infusion footprint in New Jersey and New York.